Clinical Trial Update: Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating daratumumab in combination with teclistamab or talquetamab for frail patients with newly diagnosed multiple myeloma; currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)
• TECVAYLI (TECLISTAMAB-CQYV)
• Talquetamab (talquetamab)

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: Multiple Myeloma (MM) | Phase 2 | Status: RECRUITING